- Report
- June 2026
- 160 Pages
Global
From €2589EUR$2,799USD£2,161GBP
€3236EUR$3,499USD£2,701GBP
- Report
- February 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,563GBP
€3838EUR$4,150USD£3,203GBP
- Report
- November 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- November 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- July 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,563GBP
€3838EUR$4,150USD£3,203GBP
- Report
- July 2026
- 320 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- October 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,563GBP
€3838EUR$4,150USD£3,203GBP
- Report
- June 2026
- 160 Pages
Global
From €2589EUR$2,799USD£2,161GBP
€3236EUR$3,499USD£2,701GBP
- Report
- April 2026
- 327 Pages
Global
From €4116EUR$4,450USD£3,435GBP
- Report
- February 2026
- 170 Pages
Global
From €4116EUR$4,450USD£3,435GBP
- Report
- September 2026
- 120 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- August 2026
- 109 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- August 2026
- 105 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- March 2026
- 160 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- March 2026
- 194 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- January 2026
- 164 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- July 2026
- 130 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- July 2026
- 130 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- June 2026
- 138 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2026
- 150 Pages
Global
From €3468EUR$3,750USD£2,895GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more